Cargando…
The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
BACKGROUND: There is a growing number of trials examining the effectiveness of pharmacotherapies for obesity, however, little is known about placebo and nocebo effect in these trials. Hence, we sought to examine the effect of placebo in obesity trials, to better understand the potential factors affe...
Autores principales: | Chin, Yip Han, Ng, Cheng Han, Chew, Nicholas WS, Kong, Gwyneth, Lim, Wen Hui, Tan, Darren Jun Hao, Chan, Kai En, Tang, Ansel, Huang, Daniel Q, Chan, Mark Y, Figtree, Gemma, Wang, Jiong-Wei, Shabbir, Asim, Khoo, Chin Meng, Wong, Vincent Wai-Sun, Young, Dan Yock, Siddiqui, Mohammad Shadab, Noureddin, Mazen, Sanyal, Arun, Cummings, David E., Syn, Nicholas, Muthiah, Mark Dhinesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526167/ https://www.ncbi.nlm.nih.gov/pubmed/36193169 http://dx.doi.org/10.1016/j.eclinm.2022.101685 |
Ejemplares similares
-
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals
por: Lim, Wen Hui, et al.
Publicado: (2022) -
Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
por: Ng, Cheng Han, et al.
Publicado: (2022) -
The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
por: Chew, Nicholas W.S., et al.
Publicado: (2022) -
A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022) -
DEXA Scan Body Fat Mass Distribution in Obese and Non-Obese Individuals and Risk of NAFLD—Analysis of 10,865 Individuals
por: Tan, Caitlyn, et al.
Publicado: (2022)